Osteoblast-Specific Overexpression of Human WNT16 Increases Both Cortical and Trabecular Bone Mass and Structure in Mice

• Published in: Endocrinology (Philadelphia) Vol. 157; no. 2; pp. 722 - 736
• Main Authors: Alam, Imranul, Alkhouli, Mohammed, Gerard-O'Riley, Rita L, Wright, Weston B, Acton, Dena, Gray, Amie K, Patel, Bhavmik, Reilly, Austin M, Lim, Kyung-Eun, Robling, Alexander G, Econs, Michael J
• Format: Journal Article
• Language: English
• Published: United States Endocrine Society 01.02.2016
• Subjects: Acid Phosphatase - genetics; Acid Phosphatase - metabolism; Alkaline Phosphatase - genetics; Alkaline Phosphatase - metabolism; Animals; Bone and Bones - diagnostic imaging; Bone Density - genetics; Collagen Type I - genetics; Collagen Type I - metabolism; Female; Femur - diagnostic imaging; Femur - metabolism; Humans; Isoenzymes - genetics; Isoenzymes - metabolism; Male; Mice; Mice, Transgenic; Original Research; Osteoblasts - metabolism; Osteocalcin - genetics; Osteocalcin - metabolism; Osteogenesis - genetics; Osteoporosis; Osteoprotegerin - genetics; Osteoprotegerin - metabolism; Peptides - genetics; Peptides - metabolism; RANK Ligand - genetics; RANK Ligand - metabolism; Real-Time Polymerase Chain Reaction; Retroviridae; RNA, Messenger - metabolism; Tartrate-Resistant Acid Phosphatase; Wnt Proteins - genetics; Wnt Signaling Pathway; X-Ray Microtomography
• ISSN: 0013-7227; 1945-7170
• DOI: 10.1210/en.2015-1281

Previous genome-wide association studies have identified common variants in genes associated with bone mineral density (BMD) and risk of fracture. Recently, we identified single nucleotide polymorphisms (SNPs) in Wingless-type mouse mammary tumor virus integration site (WNT)16 that were associated with peak BMD in premenopausal women. To further identify the role of Wnt16 in bone mass regulation, we created transgenic (TG) mice overexpressing human WNT16 in osteoblasts. We compared bone phenotypes, serum biochemistry, gene expression, and dynamic bone histomorphometry between TG and wild-type (WT) mice. Compared with WT mice, WNT16-TG mice exhibited significantly higher whole-body areal BMD and bone mineral content (BMC) at 6 and 12 weeks of age in both male and female. Microcomputer tomography analysis of trabecular bone at distal femur revealed 3-fold (male) and 14-fold (female) higher bone volume/tissue volume (BV/TV), and significantly higher trabecular number and trabecular thickness but lower trabecular separation in TG mice compared with WT littermates in both sexes. The cortical bone at femur midshaft also displayed significantly greater bone area/total area and cortical thickness in the TG mice in both sexes. Serum biochemistry analysis showed that male TG mice had higher serum alkaline phosphatase, osteocalcin, osteoprotegerin (OPG), OPG to receptor activator of NF-kB ligand (tumor necrosis family ligand superfamily, number 11; RANKL) ratio as compared with WT mice. Also, lower carboxy-terminal collagen cross-link (CTX) to tartrate-resistant acid phosphatase 5, isoform b (TRAPc5b) ratio was observed in TG mice compared with WT littermates in both male and female. Histomorphometry data demonstrated that both male and female TG mice had significantly higher cortical and trabecular mineralizing surface/bone surface and bone formation rate compared with sex-matched WT mice. Gene expression analysis demonstrated higher expression of Alp, OC, Opg, and Opg to Rankl ratio in bone tissue in the TG mice compared with WT littermates. Our data indicate that WNT16 is critical for positive regulation of both cortical and trabecular bone mass and structure and that this molecule might be targeted for therapeutic interventions to treat osteoporosis.